Dose Ranging Study With LT, Monotherapy, PPAR

Clinical trial NCT00240383 · COMPLETED

Trial details

NCT number: NCT00240383
Sponsor: Bristol-Myers Squibb
Status: COMPLETED
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Diabetes Mellitus II

Start date: 2002-05-01
Primary completion: 2006-06-01
Enrollment: 1260

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.